NO-Induced Neurotoxicity and Apoptotic Cell Shrinkage

NO 诱导的神经毒性和凋亡细胞萎缩

基本信息

项目摘要

DESCRIPTION (provided by applicant): Excessive stimulation of glutamate receptors of the NMDA sub-type result in the activation of nitric oxide synthase (NOS), the generation of nitric oxide (NO), and neuronal cell death. The apoptotic signaling pathway by which NO exerts its neurotoxic effects remains poorly understood. Events such as protein nitrosylation, mitochondrial dysfunction and activation of stress-activated p38 mitogen activated protein (MAP) kinase have been proposed to act as downstream effectors of NO-induced neurotoxicity. Affected neurons are thought to die by apoptosis, a form of cell death that involves the activation of cell death proteases, known as caspases. However, caspase inhibition often only delays neuronal cell death. Thus cell death determining events, upstream of casr ase activation, are likely to contribute to the commitment to cell death. Cell shrinkage is a universal event of all apoptotic cell death and involves the efflux of intracellular K+ ions. The molecular mechanism that drives K+ efflux during apoptosis is unclear. The purpose of this project will be to explore the possibility whether activation of outward voltage-gated K+ channels and subsequent cell shrinkage and mitochondrial injury via a pathway mediated by free Zn+ may constitute early events that commit neurons irreversibly to NO-induced neurotoxicity. To pursue these goals, primary cerebrocortical neurons will be analyzed using approaches such as time-lapse deconvolution microscopy, whole cell patch-clamp recording, transient transfections, biochemistry, and cell-free systems of apoptosis with isolated mitochondria. Among the specific questions that will be addressed in this project are: (1) Does NO provoke K+ efflux, enhancement of voltage-gated K+ channels, and apoptotic cell shrinkage? (2) Does stress-activated p38 MAP kinase regulate the activity of voltage-gated potassium channels and cell shrinkage? (3) Does NO provoke Zn2+ release from metallothionein (MT) which in turn results in mitochondrial damage, generation of reactive oxygen species, and p38 MAP kinase phosphorylation? Because NO plays an important role in a wide range of neurodegenerative diseases including stroke, Parkinson's disease, Alzheimer's disease, multiple sclerosis, epilepsy, and AIDS dementia, results obtained from this project could provide broad implications for the development of new therapeutic drugs to mitigate or even prevent neuronal cell loss during neurodegeneration.
描述(申请人提供):过度刺激NMDA亚型谷氨酸受体会导致一氧化氮合酶(NOS)激活、一氧化氮(NO)生成和神经元细胞死亡。 NO 发挥其神经毒性作用的细胞凋亡信号通路仍然知之甚少。蛋白质亚硝基化、线粒体功能障碍和应激激活的 p38 丝裂原激活蛋白 (MAP) 激酶的激活等事件已被认为是 NO 诱导的神经毒性的下游效应器。受影响的神经元被认为是通过细胞凋亡而死亡,这是一种细胞死亡形式,涉及细胞死亡蛋白酶(称为半胱天冬酶)的激活。然而,半胱天冬酶抑制通常只能延迟神经元细胞死亡。因此,casr 酶激活上游的细胞死亡决定事件可能有助于细胞死亡。细胞收缩是所有细胞凋亡的普遍事件,涉及细胞内 K+ 离子的流出。细胞凋亡过程中驱动 K+ 流出的分子机制尚不清楚。该项目的目的是探讨通过游离 Zn+ 介导的途径激活外向电压门控 K+ 通道以及随后的细胞收缩和线粒体损伤是否可能构成早期事件,使神经元不可逆地遭受 NO 诱导的神经毒性。为了实现这些目标,将使用延时解卷积显微镜、全细胞膜片钳记录、瞬时转染、生物化学和分离线粒体的无细胞凋亡系统等方法对原代脑皮质神经元进行分析。该项目将解决的具体问题包括:(1) NO 是否会引起 K+ 外流、电压门控 K+ 通道增强和凋亡细胞收缩? (2) 应激激活的p38 MAP激酶是否调节电压门控钾通道的活性和细胞收缩? (3) NO 是否会引起金属硫蛋白 (MT) 释放 Zn2+,进而导致线粒体损伤、活性氧的产生和 p38 MAP 激酶磷酸化? 由于一氧化氮在多种神经退行性疾病中发挥着重要作用,包括中风、帕金森病、阿尔茨海默病、多发性硬化症、癫痫和艾滋病痴呆,因此该项目获得的结果可能为开发新的治疗药物以减轻甚至预防神经退行性疾病期间神经元细胞损失提供广泛的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ella R Bossy-Wetzel其他文献

Ella R Bossy-Wetzel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ella R Bossy-Wetzel', 18)}}的其他基金

Lysine Acetylation as Switch for Optic Atrophy 1 Inactivation
赖氨酸乙酰化作为视神经萎缩 1 失活的开关
  • 批准号:
    9887403
  • 财政年份:
    2020
  • 资助金额:
    $ 37.62万
  • 项目类别:
MITOCHONDRIAL FISSION AND NEURODEGENERATION
线粒体裂变和神经变性
  • 批准号:
    8361903
  • 财政年份:
    2011
  • 资助金额:
    $ 37.62万
  • 项目类别:
MITOCHONDRIAL FISSION AND NEURODEGENERATION
线粒体裂变和神经变性
  • 批准号:
    8169595
  • 财政年份:
    2010
  • 资助金额:
    $ 37.62万
  • 项目类别:
MITOCHONDRIAL FISSION AND NEURODEGENERATION
线粒体裂变和神经变性
  • 批准号:
    7957597
  • 财政年份:
    2009
  • 资助金额:
    $ 37.62万
  • 项目类别:
Mitochondrial Fission in Huntington's Disease
亨廷顿病中的线粒体裂变
  • 批准号:
    7389367
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
MITOCHONDRIAL FISSION AND NEURODEGENERATION
线粒体裂变和神经变性
  • 批准号:
    7722407
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
Mitochondrial Fission in Huntington's Disease
亨廷顿病中的线粒体裂变
  • 批准号:
    8082349
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
Mitochondrial fission in Huntington's Disease
亨廷顿病中的线粒体裂变
  • 批准号:
    9008081
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
Mitochondrial Fission in Huntington's Disease
亨廷顿病中的线粒体裂变
  • 批准号:
    7558280
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:
Mitochondrial fission in Huntington's Disease
亨廷顿病中的线粒体裂变
  • 批准号:
    9222045
  • 财政年份:
    2008
  • 资助金额:
    $ 37.62万
  • 项目类别:

相似海外基金

Molecular mechanisms of animal tissue morphogenesis
动物组织形态发生的分子机制
  • 批准号:
    572569-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 37.62万
  • 项目类别:
    University Undergraduate Student Research Awards
Feasibility of an integrated ultrasonic enhanced extraction and magneto-immunoassay technique for rapid, in-situ measurement of antibiotic residues in animal tissue
集成超声增强提取和磁免疫分析技术快速原位测量动物组织中抗生素残留的可行性
  • 批准号:
    131482
  • 财政年份:
    2014
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Feasibility Studies
Development of novel fluorescent dye for multiphoton imaging of deep region of animal tissue
开发用于动物组织深部多光子成像的新型荧光染料
  • 批准号:
    25560411
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Cell signaling fine-tuning that supports animal tissue development and homeostasis
支持动物组织发育和稳态的细胞信号微调
  • 批准号:
    25293072
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Validation of LC-MS/MS analyses of animal tissue and feed matrices for toxicants
验证动物组织和饲料基质中有毒物质的 LC-MS/MS 分析
  • 批准号:
    9326829
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
Rapid, in-situ measurement of antibiotic residues in animal tissue
快速原位测量动物组织中的抗生素残留
  • 批准号:
    750767
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Vouchers
Validation of LC-MS/MS analyses of animal tissue and feed matrices for toxicants
验证动物组织和饲料基质中有毒物质的 LC-MS/MS 分析
  • 批准号:
    8701722
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
Validation of LC-MS/MS analyses of animal tissue and feed matrices for toxicants
验证动物组织和饲料基质中有毒物质的 LC-MS/MS 分析
  • 批准号:
    8908915
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
Cellular and molecular mechanisms shaping animal tissue architecture
塑造动物组织结构的细胞和分子机制
  • 批准号:
    183749-2009
  • 财政年份:
    2013
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Discovery Grants Program - Individual
Cellular and molecular mechanisms shaping animal tissue architecture
塑造动物组织结构的细胞和分子机制
  • 批准号:
    183749-2009
  • 财政年份:
    2012
  • 资助金额:
    $ 37.62万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了